Breast Cancer News

SAN ANTONIO — The addition of ribociclib to endocrine therapy conferred durable benefit to patients with hormone receptor-positive, HER2-negative early breast cancer, according to findings presented at San Antonio Breast Cancer Symposium.

SAN ANTONIO — The addition of either fulvestrant or letrozole to palbociclib conferred similar efficacy among patients with HER2-negative advanced breast cancer, according to data presented at San Antonio Breast Cancer Symposium.

SAN ANTONIO — Low-dose olanzapine appeared noninferior to the standard dose for controlling chemotherapy-induced nausea and vomiting without requiring delayed steroids among patients with solid tumors, according to study results.

Among routinely screened women, annual vs. biennial screening was not a strong risk factor for advanced breast cancer and accounted for a small proportion of diagnoses, according to cohort study results published in JAMA Oncology.

Patients undergoing treatment for active breast cancer reported experiencing significant financial burden from cancer care, according to survey results.

A novel digital health coaching program did not improve patient-reported outcomes among individuals with active breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.

Jack Cuzick, PhD, received the William L. McGuire Memorial Lecture Award at this year’s San Antonio Breast Cancer Symposium.

SAN ANTONIO — One in five young BRCA carriers became pregnant within 10 years of breast cancer diagnosis, according to results of an international cohort study.

SAN ANTONIO — Omission of completion axillary lymph node dissection did not increase recurrence among patients with clinically node-negative breast cancer who had positive sentinel lymph node biopsy, according to study results.

Younger postmenopausal women who underwent treatment without radiotherapy for early-stage hormone receptor-positive breast cancer experienced low 5-year recurrence rates, according to results presented at San Antonio Breast Cancer Symposium.